Triglycerides Medium Chain And Long Chain With Glucose Polymer
Recommended MetabolicRestrictedNot applicable line
Dietary management of proven inborn errors of protein metabolism.
1
Submissions
2020–20
On the record
—
ICER range
Not modelled
Cost basis
Decision on record
- Meeting Mar 2010 Recommended Medicinal food no PSD
Access path
- Mar 2020Recommended · restricted
- PBS listing · Restricted
RecommendedDeferredNot recommended
From the public summary
PBAC outcome
6.1 The PBAC recommended continuing the Restricted Benefit listing of triglycerides medium chain and long chain, Duocal, for the dietary management of proven inborn errors of protein metabolism, following its reformulation due to changes in European compositional standards.PSD · Mar 2020
6.2 The PBAC noted the NPWP were concerned that the dosing instructions for reconstitution in infant formula on the new labelling may be too open-ended, and also noted and supported the commitment from the Sponsor to engage with health care professionals to ensure caregivers are educated to prepare the formula appropriately.PSD · Mar 2020
Cost-effectiveness
Not modelled; minor submission (formulation change only, no clinical trials or economic evaluation).
Decision context
PopulationPatients requiring dietary management of proven inborn errors of protein metabolism.
Submission history
| Decided | Outcome | Comparator | ICER | Evidence |
|---|---|---|---|---|
| Mar 2020 | Recommended · restricted | — | — | Other |
Similar precedents
Triglycerides Long Chain With Glucose Polymer79%Triglycerides, Long Chain With Glucose Polymer79%Medium Chain Triglycerides; Protein Formula With Carbohydrate, Fat, Vitamins And Minerals74%Carbohydrate, Fat, Vitamins, Minerals And Trace Elements72%Triglycerides Medium Chain Formula72%Protein Hydrolysate Formula With Medium Chain Triglycerides70%Triglycerides, Long Chain; Triglycerides, Medium Chain69%Whey Protein Formula With Medium Chain Triglycerides, Carbohydrate, Vitamins And Minerals69%